Your browser doesn't support javascript.
loading
The Achieving Self-directed Integrated Cancer Aftercare Intervention for Detection of Recurrent and Second Primary Melanoma in Survivors of Melanoma: Pilot Randomized Controlled Trial.
Murchie, Peter; Constable, Lynda; Hall, Susan; Brant, William; Allan, Julia; Johnston, Marie; Masthoff, Judith; Lee, Amanda; Treweek, Shaun; Ayansina, Dolapo; Proby, Charlotte; Rahman, Kaz; Walter, Fiona; Burrows, Nigel; Durrani, Amer; Maclennan, Graeme.
Afiliación
  • Murchie P; Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom.
  • Constable L; Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom.
  • Hall S; Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom.
  • Brant W; NHS Grampian, Aberdeen, United Kingdom.
  • Allan J; Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom.
  • Johnston M; Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom.
  • Masthoff J; Department of Information and Computing Sciences, Universiteit Utrecht, Utrecht, Netherlands.
  • Lee A; Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom.
  • Treweek S; Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom.
  • Ayansina D; Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom.
  • Proby C; Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom.
  • Rahman K; NHS Grampian, Aberdeen, United Kingdom.
  • Walter F; Wolfson Institute of Preventive Medicine and Institute of Population Health Sciences, London, United Kingdom.
  • Burrows N; The Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Durrani A; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Maclennan G; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
JMIR Cancer ; 8(3): e37539, 2022 Sep 08.
Article en En | MEDLINE | ID: mdl-36074560
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Aspecto: Patient_preference Idioma: En Revista: JMIR Cancer Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Canadá
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Aspecto: Patient_preference Idioma: En Revista: JMIR Cancer Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Canadá